Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Novartis Dodges Whistleblower Lawsuit Regarding Multiple Sclerosis Drug Kickback Claims

By Vandana Singh
September 14, 2:05 PM
A federal judge dismissed a whistleblower lawsuit accusing Novartis AG (NYSE: NVS) of paying doctors kickbacks at "sham" speaker programs to boost prescriptions of its multiple sclerosis blockbuster drug Gilenya.

NVS

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine

By Vandana Singh
September 14, 9:14 AM
Pfizer Inc (NYSE:PFE) has dosed the first participants in the Phase 3 trial of its quadrivalent modified RNA (modRNA) influenza vaccine…

BNTX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Management
  • News

After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report

By Vandana Singh
September 14, 7:58 AM
Bayer AG (OTC:BAYRY) has started a hunt for CEO Werner Baumann’s successor, Bloomberg News reported, citing people close to the…

BAYRY

Read More
1 minute read
  • General
  • IPOs
  • Large Cap
  • Media
  • News
  • Penny Stocks
  • Tech

Tencent Music Pushes Hong Kong Listing As Soon As Next Week: Report

By Vandana Singh
September 14, 7:30 AM
Tencent Music Entertainment Group (NYSE:TME) is working with advisers on the preparations for its second listing in Hong Kong,…

TME

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Dividends
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Long Ideas
  • News
  • Price Target
  • Trading Ideas
  • Upgrades

Why Analysts Love This High Yield Health Care Stock, Which Just Changed Its Name

By Robert Kuczmarski
September 13, 12:19 PM
Elevance Health Inc (NYSE: ELV) (previously known as Anthem) remains one of the leading health insurers in the U.S., providing medical benefits to roughly 45 million medical members.

ELV

Read More
2 minute read
  • Buybacks
  • Dividends
  • General
  • Large Cap
  • Long Ideas
  • Mid Cap
  • News
  • Sports
  • Top Stories
  • Trading Ideas

How To Earn High Yields With Holiday Season Exposed Stocks

By Robert Kuczmarski
September 13, 12:19 PM
With inflation on the rise over the past 12 months, it should come as no surprise the consumer discretionary sector is the third-worst performing sector in the S&P 500, down roughly 20% year-to-date, as of Sept. 9.

DKS

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • News

New GE-Backed Heart Disease Study May Advance Detection To Never Before Seen Levels

By Vandana Singh
September 13, 11:15 AM
GE Healthcare and Lantheus Holdings Inc (NASDAQ:LNTH) announced that the recent Phase 3 trial of a radiotracer, [18F]flurpiridaz, has met its co-primary…

LNTH

Read More
5 minute read
  • Biotech
  • Cryptocurrency
  • General
  • Health Care
  • IPOs
  • Large Cap
  • Markets
  • Media
  • Movers
  • News
  • Tech
  • Top Stories
  • Trading Ideas

Top Financial Stories Tuesday, September 13: Elon Musk’s Takeover Set To Get Twitter Shareholder Approval, Intel Slashes Mobileye IPO Valuation, Goldman Sachs To Layoff About 500 Jobs And More…

By Vandana Singh
September 13, 8:00 AM
Wall Street Journal

AAPL

Read More
2 minute read
  • General
  • Large Cap
  • Legal
  • Media
  • News
  • SEC
  • Tech

SEC Charges VMWare With Fraud, But Settled For Just $8M In Penalty

By Vandana Singh
September 13, 7:39 AM
The Securities and Exchange Commission said it had charged the cloud computing giant VMware Inc (NYSE: VMW) for “misleading investors about its order backlog management practices.

VMW

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Large Cap
  • News

BioMarin Says One Participant Diagnosed With Leukemia In Late-Stage Hemophilia Gene Therapy Trial

By Vandana Singh
September 12, 12:50 PM
In an SEC filing, BioMarin Pharmaceutical Inc (NASDAQ:BMRN) said that, in August, a participant in its valoctocogene roxaparvovec (BMN 270)…

BMRN

Posts pagination

Previous 1 … 411 412 413 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service